Ascletis Pharma has received investigational new drug (IND) clearance from the US Food and Drug Administration (FDA) to begin ...

MetaVia has shared an update on its attempt to crash the obesity party, reporting average weight loss of 9.1% in people who ...

GLP-1 weight-loss pills appear to be just as effective as injections, with clinical trials showing similar average weight ...

"MetaVia OXM analogue agonist meets endpoints in Phase Ib weight loss trial" was originally created and published by Clinical ...

RMD is seeing rising device demand, expanding international sales and strong liquidity, but macroeconomic pressures could ...

Bright Minds Biosciences (DRUG) stays a Strong Buy after Phase 2 BMB-101 seizure-reduction data; see 2026 catalysts, ...

BMB-101 demonstrated significant anti-seizure benefit in both cohorts with favorable safety and tolerability Absence: 73.1% ...

Designing STEM classrooms that encourage students to reflect on their progress and share their stories takes intention, but ...

Structure Therapeutics Inc. (NASDAQ:GPCR) is one of the best up and coming stocks to buy according to Wall Street. On ...

Safety in pediatric sedation relies on strict guidelines and monitoring, so let's learn how providers utilize pharmacological ...

Panelists discuss how clinicians are beginning to integrate xanomeline/trospium into practice for patients who have struggled ...